Indivior reported 11.86 in PE Price to Earnings for its fiscal semester ending in March of 2026.





Pe Change Date
AstraZeneca 25.34 4.25 Jun/2026
GlaxoSmithKline 10.63 4.24 Jun/2026
Glaxosmithkline 15.09 3.43 Mar/2026
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Roche Holding 16.48 0.39 Jun/2026
West Pharmaceutical Services 42.63 10.64 Jun/2026